Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 19,657,000 | 19,050,000 | 21,407,000 | 35,166,720 | 30,764,710 |
| Cost of Goods | 9,193,000 | 8,899,000 | 10,017,000 | 14,665,190 | 13,209,330 |
| Gross Profit | 10,464,000 | 10,151,000 | 11,390,000 | 20,501,530 | 17,555,380 |
| Operating Expenses | 8,331,000 | 8,791,000 | 9,761,000 | 14,414,140 | 11,319,970 |
| Operating Income | 2,133,000 | 1,360,000 | 1,629,000 | 6,087,581 | 6,235,741 |
| Interest Expense | 145,000 | 320,000 | 359,000 | 553,135 | 519,656 |
| Other Income | 53,000 | -1,260,000 | -34,000 | 178,388 | 1,477,689 |
| Pre-tax Income | 2,041,000 | -220,000 | 1,236,000 | 5,712,834 | 7,193,774 |
| Income Tax | 53,000 | -457,000 | 110,000 | 1,086,662 | 1,447,936 |
| Net Income Continuous | 1,988,000 | 237,000 | 1,126,000 | 4,626,172 | 5,745,838 |
| Net Income Discontinuous | 588,000 | 5,726,000 | 3,602,000 | N/A | N/A |
| Net Income | $2,576,000 | $5,963,000 | $4,728,000 | $4,626,172 | $5,745,838 |
| EPS Basic Total Ops | 1.64 | 3.76 | 3.03 | 2.98 | 3.71 |
| EPS Basic Continuous Ops | 1.27 | 0.15 | 0.72 | 2.99 | 3.71 |
| EPS Basic Discontinuous Ops | 0.37 | 3.61 | 2.31 | N/A | N/A |
| EPS Diluted Total Ops | 1.62 | 3.72 | 3.01 | 2.96 | 3.69 |
| EPS Diluted Continuous Ops | 1.26 | 0.15 | 0.72 | 2.97 | 3.69 |
| EPS Diluted Discontinuous Ops | 0.36 | 3.57 | 2.29 | N/A | N/A |
| EBITDA(a) | $3,852,000 | $4,142,000 | $4,673,000 | $8,711,887 | $8,325,250 |